We are live on ! Find out more
BPTH icon

Bio-Path Holdings

Delisted

BPTH was delisted on the 18th of February, 2025.

48 hedge funds and large institutions have $26.7M invested in Bio-Path Holdings in 2016 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 5

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

12% more funds holding

Funds holding: 43 → 48 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.6% less ownership

Funds ownership: 21.32% → 20.72% (-0.6%)

27% less capital inflows, than outflows

Capital inflows: $2.17M | Capital outflows: $2.96M

Holders
48
Holders Change
+5
Holders Change %
+11.63%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
16
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

BPTH Hedge Fund Activity: Q4 2016 in Review

48 of the 4,007 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings (BPTH) for Q4 2016, worth a combined $26.7M — down 6.3% from $28.5M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new BPTH positions and 5 closed out — a net gain of 4 holders — while 16 added to existing stakes and 5 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $615K. The largest seller was Raymond James Financial Services Advisors, cutting an estimated $1.45M.

  • 48 institutional investors held Bio-Path Holdings (BPTH) as of Q4 2016, up from 43 in Q3 2016.
  • Funds reported $26.7M of Bio-Path Holdings stock for Q4 2016, down 6.3% quarter-over-quarter.
  • 9 funds opened new Bio-Path Holdings positions in Q4 2016 and 5 closed out, a net change of +4 holders.
  • The largest Bio-Path Holdings buyer in Q4 2016 was Millennium Management, an estimated $615K added.
  • The largest Bio-Path Holdings seller in Q4 2016 was Raymond James Financial Services Advisors, an estimated $1.45M sold.

Based on aggregated 13F filings for Q4 2016.